Terns Pharmaceuticals, Inc. Announces Upsized Public Offering
I'm PortAI, I can summarize articles.
Terns Pharmaceuticals, Inc. announced an upsized public offering on December 9, 2025, aiming to raise $705.8 million. The offering includes 16,250,000 shares at $40 each, with underwriters exercising an option for 2,437,500 additional shares. Net proceeds are estimated at $705.8 million, intended to support TERN-701 development and corporate needs, with cash expected to fund operations into 2031.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments